European shares closed higher on Tuesday, starting a shortened trading week on a positive note.» Read More
TOKYO— Shares were mixed in Asia on Wednesday, as weak data from China sapped upward momentum from an overnight rally on a flurry of deals in the pharmaceutical sector. Overnight, U.S. financial data and corporate earnings helped spur gains from deals by Switzerland's Novartis with Britain's GlaxoSmithKline PLC and the Eli Lilly& Co. of the U.S.
*Risk sentiment bolstered by gains in US, Europe. SYDNEY/ SINGAPORE, April 23- Asian stock markets were little moved on Wednesday after a Chinese manufacturing survey met expectations, but the Australian dollar plunged to a two-week low after data showed surprisingly low inflation in that country's economy.
SYDNEY, April 23- Asian shares crept higher on Wednesday following merger-driven gains in Europe and on Wall Street, though investors were wary in case coming figures on Chinese manufacturing again disappointed. MSCI's broadest index of Asia-Pacific shares outside Japan added 0.15 percent.
*Netflix results lift Wall St, deal talk buoys Europe. NEW YORK, April 22- Global equity markets rose on Tuesday, powered by solid U.S. corporate earnings and deal-making activity among European drugmakers, while the euro hovered near break-even on uncertainty whether the European Central Bank will further ease monetary policy.
*AstraZeneca jumps 6.3 pct on M&A talk. The STOXX Europe 600 health care index rose 3.2 percent as AstraZeneca rallied on speculation about a bid approach from U.S. major Pfizer, while a deal to swap assets boosted GlaxoSmithKline and Novartis.
*Novartis to buy GSK's oncology assets for $14.5 bln. The deals, which include Novartis buying GSK's cancer drugs and GSK acquiring Novartis' vaccines business, came hot on the heels of a newspaper report that AstraZeneca had turned down a $101 billion bid approach from Pfizer- a story that sent shares across the sector surging.
LONDON, April 22- Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GlaxoSmithKline and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal.
*Novartis to buy GSK's oncology assets for $14.5 bln. *Lilly to buy Novartis' animal health arm for $5.4 bln.
LONDON, April 22- M&A talk in the pharmaceutical sector lifted European shares on Tuesday, but failed to support the euro, which held at a two week low against the dollar on rising expectations of further policy easing by the European Central Bank.
*FTSEurofirst 300 up 0.9 pct, Euro STOXX 50 up 0.7 pct. *AstraZeneca jumps 7.4 pct on M&A talk. The euro zone's blue-chip Euro STOXX 50 index added 0.7 percent, to 3,175.96 points.
PARIS, April 22- European shares rose in early trade on Tuesday, adding to last week's rally, with AstraZeneca's stock surging on merger and acquisition talk. Shares in the UK drugmaker jumped 7.8 percent after Britain's Sunday Times reported that U.S. pharmaceutical giant Pfizer has approached its British rival to propose a 60 billion pound takeover.
There are some solid reasons why Pfizer's reported $101 billion bid for AstraZeneca makes some sense, analysts said.
Pfizer Inc may come back to bid for British drug company AstraZeneca Plc after its reported 60 billion pound takeover approach was rejected.
*Netflix climbs in extended-hours trading after results. NEW YORK, April 21- U.S. stocks advanced modestly on Monday in subdued trading as investors showed hesitation in the wake of a strong rally last week and before a slew of key earnings releases this week.
Stocks rose on Monday after the S&P 500's largest weekly advance since July.
*Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks advanced modestly on Monday as investors showed hesitation in the wake of a strong rally last week and ahead of key earnings releases. The S&P 500 posted its best week since July last week, boosted by results from such names as General Electric Co and Morgan Stanley.
NEW YORK— A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:. Crawford& Co. class B rose 8.5 percent to $11.92. Crawford& Co. class A rose 4.5 percent to $9.77.
*Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks rose slightly on Monday as investors found few reasons to push indexes sharply higher following a strong rally last week and ahead of key earnings releases.
*Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks were flat on Monday ahead of key earnings releases as investors found few reasons to push indexes sharply higher following a strong rally last week. The S&P 500 posted its best week since July last week, boosted by results from such names as General Electric Co and Morgan Stanley.
Some of the names on the move ahead of the open.